AOA Dx Inc. is a US-based diagnostics biotechnology company with offices in Boston, New York, and London, focusing on the early detection of ovarian cancer.
Subscribe to see AOA DX Inc.’s full profile → the full roster, investors in every round, weekly hiring history and every corporate event
AOA DX Inc. is a healthcare company headquartered in Denver, United States. Its most recent funding round raised $8.1M in October 2025. Xcout tracks 16 named people at AOA DX Inc., including Oriana Papin-Zoghbi (President).
As of 16 November 2026. Source: Xcout Intel.
10 more named people on record for AOA DX Inc., with roles, board committees and tenure — see the full roster →
The 3 most recent:
| Date | Round | Amount | Investors |
|---|---|---|---|
| — | $8.1M | — | |
| Seed | $2.5M | — | |
| SEC Form D filing | $1.8M | — |
Who invested in each round, lead investors, valuations and the co-investor graph — open the full funding history →
A funding-flow diagram of the 7 named investors across 3 rounds: who backed which round, who led it, and who came back for the next one.
Sign in to see it, or subscribe for the full funding history →
A few of AOA DX Inc.'s closest competitors — see the full list of competitors and alternatives →
EarlyDiagnostics, also known as EarlyDx, is a clinical-stage precision diagnostics company that develops non-invasive liquid biopsy technologies and genomics platforms for early cancer detection.
Amoy Dx is a diagnostic company dedicated to transforming cancer care by breaking barriers in precision oncology. The company develops specialized genomic tools and diagnostics products, such as the AmoyDx Essential NGS Panel used in clinical trials. It operates as a visionary enterprise within the precision medicine and diagnostics sector.
A3P Biomedical is a Swedish private diagnostics company that specializes in advanced prostate cancer screening. Its lead product, Stockholm3, combines protein markers, genetic markers, and clinical data using an advanced algorithm to detect aggressive prostate cancer.
Celsee Diagnostics is a company operating in the rare disease diagnostics and liquid biopsy market. Based in Maryland, the company is involved in developing and assessing advanced healthcare technologies for cancer and genomic detection.
Innocras is a genomic analysis and cancer big data company founded in South Korea by physician-scientists from KAIST, maintaining research and corporate presence in both the United States and Korea. The company specializes in advanced cancer diagnostics and genomic technology to support precision oncology.
Funding rounds, acquisitions, new executives, launches and expansions, each with a two-line summary and a link to the source. One short email a day, only when there is news.
Free: up to 5 companies, daily. Subscribers also follow whole sectors and saved filters (M&A in Israel, AI funding…), get instant alerts, in-app notifications and signed webhooks, and open the full profile behind every name. Subscribe →
Something wrong or missing about AOA DX Inc.? Suggest a correction · Work at AOA DX Inc.? Claim this profile
Post the link and the card appears automatically — each network fetches the image itself.